New pill tested to slow Parkinson's progression
Disease control
Completed
This study tested a new daily pill called IkT-148009 in people recently diagnosed with Parkinson's disease who were not yet taking other Parkinson's medications. Over 12 weeks, researchers compared three different doses of the drug to a placebo (a pill with no medicine) to see if…
Phase: PHASE2 • Sponsor: ABLi Therapeutics, Inc. • Aim: Disease control
Last updated Apr 02, 2026 04:11 UTC